CDSCO Registration for Class D Medical Devices: Complete 2026 Guide For Highest-Risk Medical Device License — Device List, Clinical Investigation Requirements, Process, & Fees

• CDSCO Registration For Class D Medical Devices classified under 83 devices — India's highest-risk category covering implantable, life-sustaining, and infection-controlling devices.
• Class D demands clinical investigation data, mandatory Notified Body assessment, and CDSCO's most stringent pre-market scrutiny.
• Covers 14 speciality categories — neurology, radiotherapy, oncology, cardiovascular, paediatrics and more.
• 2026: All Class D license applications processed via CDSCO Sugam portal — fully digital, with mandatory post-market vigilance obligation.

What is CDSCO Registration For Class D Medical Devices?

Class D medical devices are India's highest-risk, most strictly regulated medical device category under the Medical Devices Rules (MDR) 2017. If your product is classified as Class D, it is either implantable in the human body, life-sustaining, or directly involved in infection control — and a failure or defect in such a device can cause serious harm or death.

The Central Drugs Standard Control Organization (CDSCO), India's apex medical device regulator under the Ministry of Health and Family Welfare, applies its most rigorous pre-market licensing framework to Class D devices. Unlike lower-risk classes, Class D licensing under Chapter IV of MDR 2017 mandates clinical investigation data, mandatory Notified Body assessment, comprehensive technical documentation, and GMP inspection — before a single device can be legally sold in India.

This is not a process to approach casually. Class D devices include deep brain stimulators, implantable pacemakers, replacement heart valves, brachytherapy systems, neurovascular stents, and other devices where patient safety is directly and immediately at stake. CDSCO's Class D framework is designed to ensure that every such device reaching Indian patients has been rigorously validated for safety and performance.

India's Medical Device Risk Classification — Class D at the Top

MDR 2017 classifies all medical devices into four risk-based tiers. Class D occupies the highest tier — with correspondingly strict regulatory obligations:

Why Class D is different from everything else: Class D devices are in a category where failure is not just a quality issue — it is a patient safety emergency. An implantable pacemaker that malfunctions, a neurovascular stent that fractures, or a brachytherapy system that miscalibrates can cause immediate, irreversible harm. That is why CDSCO demands the highest standard of clinical evidence, manufacturing control, and post-market vigilance for this class.

Who Needs a CDSCO Class D Medical Device License?

A CDSCO Class D license is legally mandatory for every entity that makes Class D devices available in the Indian market:

• Indian manufacturers producing Class D devices for sale anywhere in India — regardless of company size, turnover, or business stage
• Importers bringing Class D devices from foreign countries into India — the Indian Authorized Agent (IAA) holds the import license on behalf of the foreign manufacturer
• Foreign manufacturers selling Class D devices in India through a registered IAA — the IAA is the legal responsible party in India
• Contract manufacturers producing Class D devices on behalf of brand owners — the license must cover the actual manufacturing site and device scope
• Relabellers or repackagers of imported Class D devices — treated as importers and must hold a valid import license
• Companies whose devices have been upgraded to Class D following CDSCO notification revisions or reclassification decisions

Eligibility Criteria for CDSCO Class D Device License

Class D eligibility requirements are the most demanding in India's medical device regulatory framework. Every criterion below must be met before a license application is filed:

Complete List of CDSCO Class D Medical Devices — All 83 Devices

The table below contains the complete official CDSCO Class D medical device list sourced directly from Annexure II of CDSCO's classification document. All 83 Class D devices across 14 medical speciality categories are listed here. This is your definitive reference for confirming whether your device falls under India's most stringent regulatory pathway.

Class D Medical Devices by Medical Speciality Category

All 83 Class D devices span 14 medical speciality categories. Here is the complete breakdown:

Documents Required for CDSCO Class D Medical Device License

Class D requires the most comprehensive documentation package in India's entire medical device regulatory framework. Every document below must be complete, current, and from recognized sources before submission:

Documents for Indian Manufacturers — Class D Manufacturing License

Additional Documents for Importers — Class D Import License

Step-by-Step Process: How to Get a CDSCO Class D License in 2026

The Class D licensing process is India's most rigorous medical device regulatory pathway. Here is the complete, accurate step-by-step guide for 2026:

Step 1: Confirm Your Device is Class D and Plan Your Regulatory Strategy

• Cross-reference your product name against the official CDSCO Class D list (Annexure II — in this guide)
• Verify the intended use matches the CDSCO classification description exactly — slight differences in intended use can place a device in Class C
• For novel or borderline devices, raise a formal classification query with CDSCO's medical device division before investing in clinical investigation or documentation
• Engage a senior CDSCO-experienced Regulatory Affairs professional immediately — Class D is not an application type to attempt without specialist guidance
• Develop a full regulatory strategy: clinical investigation plan, Notified Body selection, ISO 13485 certification timeline, and application submission milestones

Step 2: Design and Manufacturing GMP Compliance

• Implement a fully functioning ISO 13485 QMS — for Class D, design controls (Clause 7.3), risk management, and post-market surveillance are the most intensively reviewed sections
• Ensure manufacturing facility compliance with Schedule M of MDR 2017 at Class D standards — validated cleanrooms, validated sterilization processes (for sterile implantables), documented process controls
• Obtain ISO 13485 certification from a NABCB-accredited certification body (Indian manufacturer) or ILAC-recognized certification body (foreign manufacturer) with explicit Class D device scope
• For sterile implantable devices: validate all sterility assurance processes to SAL 10⁻⁶ and obtain sterilization validation reports

Step 3: Complete Full Technical Documentation

• Compile the complete design dossier — design history file, all design verification and validation test reports, design review records
• Complete the full ISO 14971:2019 risk management file — hazard identification through residual risk evaluation with benefit-risk analysis
• Complete ISO 10993 biocompatibility testing for all patient-contacting and implanting materials — commission a NABL-accredited or ILAC-recognized test laboratory
• For software-containing Class D devices: complete IEC 62304 software lifecycle documentation and cybersecurity assessment
• Prepare device labelling and IFU in compliance with MDR 2017 Schedule III, including implant card content for implantable devices
• Commission all applicable performance and safety tests from NABL-accredited labs

Step 4: Clinical Investigation (Where Required by CDSCO)

• For most Class D devices, CDSCO requires prospective clinical investigation data — not just literature evidence
• Design the clinical investigation protocol in compliance with MDR 2017 Chapter VI, ISO 14155 (clinical investigation of medical devices), and applicable GCP guidelines
• Obtain Ethics Committee approval from a CDSCO-registered / ICMR-recognized Ethics Committee before initiating investigation
• File a Clinical Investigation Application with CDSCO if the investigation involves Indian subjects — separate approval required before investigation commencement
• Conduct the investigation, collect data, and prepare the clinical investigation report to the standard required for MDR 2017 Schedule II-A compliance
• Note: clinical investigation is a multi-year process for complex Class D devices — plan regulatory timelines accordingly

Step 5: Notified Body Assessment

• Select a Notified Body recognized under EU MDR 2017/745 or equivalent, accepted by CDSCO for Class D device assessment
• Submit the full technical documentation and clinical evaluation report for Notified Body review
• Address all Notified Body questions and requests for additional information — this process can take 6–18 months for complex Class D devices
• Obtain the Notified Body certificate and assessment report — these are mandatory documents in your CDSCO license application

Step 6: Register on CDSCO Sugam Portal and Prepare Application

• Create or update your company profile on sugamya.cdsco.gov.in with all current details — GSTIN, PAN, manufacturing site address, authorized signatory
• For importers: ensure IAA profile is fully established, linked to the foreign manufacturer account, and all IAA documents are current
• Organize all documentation in PDF format, clearly labeled, within portal file size limits

Step 7: File Application (Form MD-3 / MD-15) and Pay Fee

• Select 'Apply for Class D Manufacturing License' or 'Apply for Class D Import License' on the Sugam portal
• Complete Form MD-3 (manufacturers) or MD-15 (importers) — all device names must exactly match the official CDSCO Class D classification list
• Upload all required documents in the correct format to each designated document section
• Pay the prescribed Class D licensing fee online through the Sugam portal payment gateway
• Save and note your application reference number — this is your primary tracking identifier for all future correspondence

Step 8: CDSCO Expert Review, Queries, and Clinical Data Assessment

• CDSCO assigns a senior medical device reviewer with relevant clinical expertise for Class D applications
• The review is the most detailed of any device class — clinical evidence quality, Notified Body report conclusions, biocompatibility data, and risk management completeness are all deeply assessed
• Technical queries will be raised on the Sugam portal — respond promptly and completely through the portal only
• CDSCO may request additional clinical evidence, specific test reports, or expert consultation meetings for complex Class D devices
• All queries must be answered within the stipulated deadline — unanswered queries lead to automatic application closure

Step 9: Manufacturing Facility Inspection (Most Rigorous in MDR 2017)

• CDSCO conducts the most thorough facility inspection of any device class for Class D manufacturing licenses
• Inspectors verify Schedule M GMP compliance at the highest standard — cleanroom qualification, sterility assurance validation, equipment calibration, process validation, and complete QMS implementation
• All inspection Non-Conformances must be resolved with documented CAPA before license issuance
• Critical Non-Conformances may require a re-inspection, adding months to the timeline
• Import license applications require full review of the foreign manufacturer's GMP documentation — an on-site inspection of the foreign facility may be requested

Step 10: License Issuance — Manufacturing License (Form MD-5) or Import License (Form MD-15)

• After successful document review, clinical evidence acceptance, Notified Body assessment validation, and inspection clearance — CDSCO issues the license
• Download the digital license certificate from the Sugam portal — it is legally valid
• The license number must be printed on all device labels and referenced in all regulatory submissions
• Typical total timeline: 18–36 months from complete application submission for manufacturing licenses (including clinical investigation time); 12–24 months for import licenses with fully complete documentation
• Implant the license review date in your compliance calendar — renewal preparation must begin at least 6 months before expiry

CDSCO Fees for Class D Medical Device License

The Class D licensing fee structure under MDR 2017's Second Schedule reflects the highest fee tier, consistent with the intensity of the review process:

Validity and Renewal of CDSCO Class D Device License

Managing Class D license validity is a mission-critical compliance obligation. An expired Class D license is the same as no license — with immediate legal consequences:

Key Benefits of Obtaining a CDSCO Class D Medical Device License

The Class D licensing process is the most demanding in India's device framework — but the business and ethical benefits of getting it right are profound:

1. The Only Legitimate Gateway to India's Premium Device Market

A valid CDSCO Class D license is the only legal pathway to manufacturing, importing, or selling Class D devices in India. There is no alternative route, no informal market access, and no grace period. For companies with genuinely Class D products, the license is not optional — it is the foundation of every sales conversation, every hospital contract, and every distribution agreement.

2. Access to Cardiology, Neurology, and Oncology Speciality Markets

Class D devices serve the highest-value clinical specialties in Indian healthcare — implantable cardiac devices, neurostimulators, deep brain stimulators, brachytherapy systems. These specialties are served by India's largest and best-funded hospitals, which require valid CDSCO licenses as a non-negotiable procurement prerequisite.

3. Government Procurement — High-Value, Long-Term Contracts

National health programs, AIIMS, state government hospitals, and defence healthcare (ECHS, CGHS) procure Class D devices through large, multi-year contracts. The GeM portal and central/state procurement committees all mandate valid CDSCO Class D licenses. The regulatory investment unlocks contract values that dwarf the compliance cost.

4. Clinical Credibility — The Highest Standard of Device Validation

A CDSCO Class D license, backed by clinical investigation data and Notified Body assessment, is the strongest possible clinical credibility signal in the Indian market. Cardiologists, neurosurgeons, and oncologists who implant or apply these devices need to trust them with their patients' lives. A CDSCO Class D license tells them that trust is earned and verified.

5. Global Regulatory Alignment — Easier Export Pathway

The documentation and clinical evidence generated for CDSCO Class D licensing — ISO 13485, ISO 14971, ISO 10993, IEC 62304, clinical evaluation per Schedule II-A — is aligned with the highest global regulatory standards (EU MDR, USFDA PMA, TGA Class III). This means the investment in Indian Class D compliance simultaneously advances your global regulatory portfolio.

6. Free Sale Certificate (FSC) for Export

CDSCO issues Free Sale Certificates only to licensed manufacturers. Your Class D manufacturing license is the prerequisite for getting an FSC — required by virtually every international importing market. Your Indian compliance directly supports your export access.

7. Foundation for India's Most Valuable Device Market Segment

Implantable devices, neurostimulators, and brachytherapy systems represent some of the highest per-unit revenue and margin medical products globally. India's growing cardiac, neurological, and oncology treatment market represents a multi-thousand-crore opportunity. Class D licensing is the investment that unlocks this market.

Class A vs B vs C vs D — Complete Regulatory Comparison

A side-by-side comparison of all four device classes to help you understand exactly what Class D demands:

Critical Mistakes That Derail CDSCO Class D License Applications

Class D applications have the longest review timelines and highest deficiency rates in CDSCO's licensing system. Here are the most consequential mistakes to avoid:

• Submitting a clinical evaluation report based only on literature review when CDSCO determines prospective clinical investigation data is required for that specific device type
• Biocompatibility test reports that cover only cytotoxicity and sensitization — for implantable Class D devices, the full ISO 10993 series (including implantation, genotoxicity, systemic toxicity, hemocompatibility) is mandatory
• ISO 13485 certificate with a scope that does not explicitly cover the Class D device type being applied for — scope must match precisely
• Notified Body certificate from a body not recognized by CDSCO or not listed under EU MDR 2017/745 — always verify Notified Body recognition status before commissioning assessment
• Site Master File and actual facility conditions that are inconsistent — Class D inspections are the most thorough, and inconsistencies are treated as critical non-conformances
• Software-integrated Class D devices without IEC 62304 documentation and cybersecurity risk assessment
• Device names in the application that do not exactly match the CDSCO Class D classification — even minor word variations trigger classification queries and delays
• FSC, CE certificates, or Notified Body certificates that expire during the review period — all certificates must remain valid through the entire CDSCO review cycle
• Failing to respond to Sugam portal queries within the stipulated deadline — Class D queries often require specialist input; build response capacity before filing
• Not establishing a Materiovigilance system before receiving the license — CDSCO auditors check this during post-license inspections
• Filing a Class D application without a complete post-market clinical follow-up (PMCF) plan — this is mandatory for all Class D devices

Conclusion — CDSCO Class D Licensing Is a Patient Safety Commitment

CDSCO Class D medical device registration is not just India's most demanding regulatory process — it is a patient safety commitment. Every clinical investigation data point, every biocompatibility test, every Notified Body assessment, and every GMP inspection report in a Class D license application represents the evidence base that says: this device is safe to implant in a patient, safe to sustain a life with, safe to use in cancer treatment. That weight is why the process is demanding, and it is why the process is right.

Companies that approach Class D licensing with that mindset — investing in robust clinical evidence, genuinely compliant manufacturing, and a culture of patient safety — find the regulatory process rigorous but navigable. Companies that try to shortcut clinical evidence, use non-recognized testing labs, or misrepresent facility capabilities face delays, rejections, enforcement actions, and ultimately, damage to the patients they set out to serve.

The 83 Class D devices listed in this guide come directly from CDSCO's official Annexure II classification. Use this list to confirm your device, develop your regulatory strategy early, invest in the right clinical and technical evidence, and pursue India's Class D license as the credential of trust it represents.

Frequently Asked Questions